Valganciclovir
| CAS No. | 175865-60-8 | Cat. No. | BCP28511 |
| Name | Valganciclovir | ||
| Synonyms | RS 079070-194; RO 107-9070/194; RS-79070-194; RS-079070-194; Ganciclovir L-valyl ester; | ||
| Formula | C14H22N6O5 | M. Wt | 354.36 |
| Description | Valganciclovir is an L-valyl ester (prodrug) of ganciclovir that exists as a mixture of two diastereomers. After oral administration, both diastereomers are rapidly converted to ganciclovir by intestinal and hepatic esterases. Ganciclovir is a synthetic analogue of 2'-deoxyguanosine, which inhibits replication of human CMV in cell culture and in vivo. The reported EC50 values of ganciclovir that inhibit human CMV replication in cell culture (laboratory and clinical isolates) have ranged from 0.08 to 22.94 μM (0.02 to 5.75 mcg/mL). | ||
| Pathways | Microbiology/Virology | ||
| Targets | CMV | ||
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.